Alzheimer's Disease

Showing NaN - NaN of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • San Diego, California
  • +99 more
Oct 6, 2023

Program to Identify Participants at High Risk for Amyloid

Not yet recruiting
  • Alzheimer's Disease
  • No Intervention
  • Lady Lake, Florida
  • +1 more
Sep 12, 2023

Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +100 more
Oct 18, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Active, not recruiting
  • Alzheimer's Disease
  • Garden Grove, California
  • +48 more
Sep 1, 2022

Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

Recruiting
  • Alzheimer's Disease
  • Santa Ana, California
  • +19 more
Aug 9, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)

Completed
  • Alzheimer's Disease
  • Sun City, Arizona
  • +130 more
May 23, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +132 more
Feb 16, 2022

Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +138 more
Dec 10, 2021

Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)

Completed
  • Agitation
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +43 more
Oct 29, 2021

Alzheimer's Disease Trial in Worldwide (ABBV-8E12)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +56 more
Nov 15, 2021

Alzheimer's Disease Trial in Worldwide (ALZT-OP1a, ALZT-OP1b, Placebo ALZT-OP1a)

Completed
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +120 more
Nov 8, 2021

Cognitive Dysfunction, Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

Terminated
  • Cognitive Dysfunction
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +21 more
Aug 19, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Phoenix, Arizona
  • +180 more
Aug 9, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Birmingham, Alabama
  • +179 more
Aug 9, 2021

Alzheimer's Disease Trial in Worldwide (ABT-126)

Terminated
  • Alzheimer's Disease
  • Long Beach, California
  • +38 more
Jul 29, 2021

Alzheimer's Disease Trial in United States (AC-1204, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +81 more
Jul 30, 2021

Alzheimer's Disease, Mild Cognitive Impairment Trial in United States (ABT-957, Placebo)

Terminated
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Cypress, California
  • +8 more
Jul 2, 2021

Alzheimer's Disease Trial in United States (ABT-957, Placebo for ABT-957)

Terminated
  • Alzheimer's Disease
  • Glendale, California
  • +3 more
Jul 2, 2021

Dementia, Alzheimer's Disease Trial in Orlando (UCF Caregiver Support Group, Community Support Groups)

Completed
  • Dementia
  • Alzheimer's Disease
  • UCF Caregiver Support Group
  • Community Support Groups
  • Orlando, Florida
    University of Central Florida
Jun 22, 2021

Alzheimer's Disease Trial in Canada, United States (Azeliragon 5mg)

Terminated
  • Alzheimer's Disease
  • Azeliragon 5mg
  • Phoenix, Arizona
  • +70 more
May 28, 2021

Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +114 more
May 6, 2021

Alzheimer's Disease Trial in Worldwide (Elenbecestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Chandler, Arizona
  • +257 more
Jan 14, 2021

Alzheimer's Disease Trial in United States (Active Comparator: A, Placebo Comparator B, Active Comparator B)

Completed
  • Alzheimer's Disease
  • Active Comparator: A
  • +3 more
  • Garden Grove, California
  • +7 more
Nov 20, 2020

Alzheimer's Disease Trial in Worldwide (PF-04447943, Placebo)

Completed
  • Alzheimer's Disease
  • Northport, Alabama
  • +43 more
Oct 28, 2020